 In the present study, Stereotactic Body Radio-Therapy SBRT will be combined to the standard systemic treatment for first line treatment of metastatic breast, colorectal and VADS upper aerodigestive tract cancers. Indeed, these treatments have in common the use of target therapies capable of ADCC. 